116 related articles for article (PubMed ID: 22821063)
1. Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects.
Reddy P; Martinez-Martin P; Rizos A; Martin A; Faye GC; Forgacs I; Odin P; Antonini A; Chaudhuri KR
Clin Neuropharmacol; 2012; 35(5):205-7. PubMed ID: 22821063
[TBL] [Abstract][Full Text] [Related]
2. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
3. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
[TBL] [Abstract][Full Text] [Related]
4. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
5. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Kim HJ; Park SY; Cho YJ; Hong KS; Cho JY; Seo SY; Lee DH; Jeon BS
J Neurol Sci; 2009 Dec; 287(1-2):200-4. PubMed ID: 19700173
[TBL] [Abstract][Full Text] [Related]
6. Effect of duodenal levodopa infusion on blood pressure and sweating.
Pursiainen V; Lyytinen J; Pekkonen E
Acta Neurol Scand; 2012 Oct; 126(4):e20-4. PubMed ID: 22329867
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
8. EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.
Martinez-Martin P; Reddy P; Katzenschlager R; Antonini A; Todorova A; Odin P; Henriksen T; Martin A; Calandrella D; Rizos A; Bryndum N; Glad A; Dafsari HS; Timmermann L; Ebersbach G; Kramberger MG; Samuel M; Wenzel K; Tomantschger V; Storch A; Reichmann H; Pirtosek Z; Trost M; Svenningsson P; Palhagen S; Volkmann J; Chaudhuri KR
Mov Disord; 2015 Apr; 30(4):510-6. PubMed ID: 25382161
[TBL] [Abstract][Full Text] [Related]
9. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
10. Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.
Pålhagen SE; Dizdar N; Hauge T; Holmberg B; Jansson R; Linder J; Nyholm D; Sydow O; Wainwright M; Widner H; Johansson A
Acta Neurol Scand; 2012 Dec; 126(6):e29-33. PubMed ID: 22690905
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study.
Suwantamee J; Nidhinandana S; Srisuwananukorn S; Laptikultham S; Pisarnpong A; Chankrachang S; Bundhukul A
J Med Assoc Thai; 2004 Nov; 87(11):1293-300. PubMed ID: 15825702
[TBL] [Abstract][Full Text] [Related]
12. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.
Isacson D; Bingefors K; Kristiansen IS; Nyholm D
Acta Neurol Scand; 2008 Dec; 118(6):379-86. PubMed ID: 18547273
[TBL] [Abstract][Full Text] [Related]
13. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
[TBL] [Abstract][Full Text] [Related]
14. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.
Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
Mov Disord; 2007 Oct; 22(13):1866-70. PubMed ID: 17659634
[TBL] [Abstract][Full Text] [Related]
15. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
Murata M; Hasegawa K; Kanazawa I;
Neurology; 2007 Jan; 68(1):45-50. PubMed ID: 17200492
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.
Ziegler M; Castro-Caldas A; Del Signore S; Rascol O
Mov Disord; 2003 Apr; 18(4):418-25. PubMed ID: 12671949
[TBL] [Abstract][Full Text] [Related]
17. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
18. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
19. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.
Gómez-Esteban JC; Zarranz JJ; Lezcano E; Tijero B; Luna A; Velasco F; Rouco I; Garamendi I
Eur Neurol; 2007; 57(3):161-5. PubMed ID: 17213723
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in Parkinson's disease--Indian scenario.
Ray J; Das SK; Gangopadhya PK; Roy T
J Assoc Physicians India; 2006 Jan; 54():17-21. PubMed ID: 16649733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
